A novel mitotropic oligolysine nanocarrier: Targeted delivery of covalently bound D-Luciferin to cell mitochondria

Mitochondrion

Volumn 11, Issue 6, 2011, Pages 982-986

  Theodossiou, Theodossis A ^a   Sideratou, Zili ^a   Tsiourvas, Dimitris ^a   Paleos, Constantinos M ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

Confocal microscopy; D luciferin; Mitochondrial targeting; Nanocarriers; Oligolysine; Triphenylphosphonium

Indexed keywords

CATION; LUCIFERIN; NANOCARRIER; OLIGOLYSINE; OLIGOMER; PHOSPHINE DERIVATIVE; TRIPHENYLPHOSPHONIUM CATION; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CHEMICAL STRUCTURE; CHEMOLUMINESCENCE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROSTATE CANCER; STEADY STATE; SYNTHESIS;

BENZOTHIAZOLES; CARRIER PROTEINS; DRUG DELIVERY SYSTEMS; HUMANS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; ORGANOSELENIUM COMPOUNDS; POLYLYSINE; PROTEIN TRANSPORT;

EID: 82755182721     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2011.08.004     Document Type: Article

References (31)

1. Adlam V.J., Harrison J.C., Porteous C.M., James A.M., Smith R.A., Murphy M.P., Sammut I.A. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. The FASEB Journal 2005, 19:1088-1095.
2. Armstrong J.S. Mitochondrial medicine: pharmacological targeting of mitochondria in disease. British Journal of Pharmacology 2007, 151:1154-1165.
3. Boddapati S.V., Tongcharoensirikul P., Hanson R.N., D'Souza G.G., Torchilin V.P., Weissig V. Mitochondriotropic liposomes. Journal of Liposome Research 2005, 15:49-58.
4. Boddapati S.V., D'Souza G.G., Erdogan S., Torchilin V.P., Weissig V. Organelle-targeted nanocarriers: specific delivery of liposomal ceramide to mitochondria enhances its cytotoxicity in vitro and in vivo. Nano Letters 2008, 8:2559-2563.
5. Carew J.S., Huang P. Mitochondrial defects in cancer. Molecular Cancer 2002, 1:9.
6. Cocheme H.M., Kelso G.F., James A.M., Ross M.F., Trnka J., Mahendiran T., Asin-Cayuela J., Blaikie F.H., Manas A.R., Porteous C.M., Adlam V.J., Smith R.A., Murphy M.P. Mitochondrial targeting of quinones: therapeutic implications. Mitochondrion 2007, 7(Suppl):S94-S102.
7. Collet H., Souaid E., Cottet H., Deratani A., Boiteau L., Dessalces G., Rossi J.C., Commeyras A., Pascal R. An expeditious multigram-scale synthesis of lysine dendrigraft (DGL) polymers by aqueous N-carboxyanhydride polycondensation. Chemistry A European Journal 2010, 16:2309-2316.
8. Cottet H., Martin M., Papillaud A., Souaid E., Collet H., Commeyras A. Determination of dendrigraft poly-l-lysine diffusion coefficients by Taylor dispersion analysis. Biomacromolecules 2007, 8:3235-3243.
9. Cuchelkar V., Kopeckova P., Kopecek J. Novel HPMA copolymer-bound constructs for combined tumor and mitochondrial targeting. Molecular Pharmaceutics 2008, 5:776-786.
10. Del Gaizo V., Payne R.M. A novel TAT-mitochondrial signal sequence fusion protein is processed, stays in mitochondria, and crosses the placenta. Molecular Therapy 2003, 7:720-730.
11. Dessolin J., Schuler M., Quinart A., De Giorgi F., Ghosez L., Ichas F. Selective targeting of synthetic antioxidants to mitochondria: towards a mitochondrial medicine for neurodegenerative diseases?. European Journal of Pharmacology 2002, 447:155-161.
12. DiMauro S. Mitochondrial diseases. Biochimica et Biophysica Acta 2004, 1658:80-88.
13. Duchen M.R. Roles of mitochondria in health and disease. Diabetes 2004, 53(Suppl 1):S96-S102.
14. Fernandez-Carneado J., Van Gool M., Martos V., Castel S., Prados P., de Mendoza J., Giralt E. Highly efficient, nonpeptidic oligoguanidinium vectors that selectively internalize into mitochondria. Journal of the American Chemical Society 2005, 127:869-874.
15. Horobin R.W., Trapp S., Weissig V. Mitochondriotropics: a review of their mode of action, and their applications for drug and DNA delivery to mammalian mitochondria. Journal of Controlled Release 2007, 121:125-136.
16. Horton K.L., Stewart K.M., Fonseca S.B., Guo Q., Kelley S.O. Mitochondria-penetrating peptides. Chemistry & Biology 2008, 15:375-382.
17. Huang K., Voss B., Kumar D., Hamm H.E., Harth E. Dendritic molecular transporters provide control of delivery to intracellular compartments. Bioconjugate Chemistry 2007, 18:403-409.
18. Leach F.R., Webster J.J. Commercially available firefly luciferase reagents. Methods in Enzymology 1986, 133:51-70.
19. Lei W., Xie J., Hou Y., Jiang G., Zhang H., Wang P., Wang X., Zhang B. Mitochondria-targeting properties and photodynamic activities of porphyrin derivatives bearing cationic pendant. Journal of photochemistry and photobiology 2010, 98:167-171.
20. Lim C.S. Organelle-specific targeting in drug delivery and design. Advanced Drug Delivery Reviews 2007, 59:697.
21. Mukhopadhyay A., Weiner H. Delivery of drugs and macromolecules to mitochondria. Advanced Drug Delivery Reviews 2007, 59:729-738.
22. Murphy M.P., Smith R.A. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annual Review of Pharmacology and Toxicology 2007, 47:629-656.
23. Reardon W., Ross R.J., Sweeney M.G., Luxon L.M., Pembrey M.E., Harding A.E., Trembath R.C. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 1992, 340:1376-1379.
24. Sibrian-Vazquez M., Nesterova I.V., Jensen T.J., Vicente M.G. Mitochondria targeting by guanidine- and biguanidine-porphyrin photosensitizers. Bioconjugate Chemistry 2008, 19:705-713.
25. Smith R.A., Kelso G.F., James A.M., Murphy M.P. Targeting coenzyme Q derivatives to mitochondria. Methods in Enzymology 2004, 382:45-67.
26. Tauskela J.S. MitoQ-a mitochondria-targeted antioxidant. IDrugs 2007, 10:399-412.
27. Theodossiou T., Hothersall J.S., Woods E.A., Okkenhaug K., Jacobson J., MacRobert A.J. Firefly luciferin-activated rose bengal: in vitro photodynamic therapy by intracellular chemiluminescence in transgenic NIH 3T3 cells. Cancer Research 2003, 63:1818-1821.
28. Tsogas I., Theodossiou T., Sideratou Z., Paleos C.M., Collet H., Rossi J.C., Romestand B., Commeyras A. Interaction and transport of poly(l-lysine) dendrigrafts through liposomal and cellular membranes: the role of generation and surface functionalization. Biomacromolecules 2007, 8:3263-3270.
29. Weissig V., Cheng S.M., D'Souza G.G. Mitochondrial pharmaceutics. Mitochondrion 2004, 3:229-244.
30. Weissig V., Boddapati S.V., Cheng S.M., D'Souza G.G. Liposomes and liposome-like vesicles for drug and DNA delivery to mitochondria. Journal of Liposome Research 2006, 16:249-264.
31. Yamada Y., Harashima H. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases. Advanced Drug Delivery Reviews 2008, 60:1439-1462.